```html

Xeroderma (Photosensitivity)

What is Xeroderma (Photosensitivity)?

Xeroderma, also known as photosensitivity, describes an abnormal skin reaction to ultraviolet (UV) radiation or visible light. People with xeroderma develop redness, burning, itching, swelling, or blistering after relatively short periods of sun exposure—often far less than the time required for a normal tan. The term “xeroderma” is derived from Greek roots meaning “dry skin,” reflecting the common finding of rough, scaly, or cracked skin after sun‑induced injury. While occasional sunburn is normal, photosensitivity signals an underlying disorder that affects the skin’s ability to protect or repair itself after UV exposure.

Because sunlight triggers a cascade of cellular events—including DNA damage, inflammation, and pigment changes—any condition that interferes with these pathways can produce xeroderma. Recognizing the pattern of skin changes, identifying the underlying cause, and taking steps to limit UV exposure are essential for preventing long‑term complications such as premature aging, actinic keratoses, and skin cancer.

Common Causes

Photosensitivity can be inherited, drug‑induced, or associated with systemic illnesses. The most frequently encountered causes are:

• Genetic Xeroderma Pigmentosum (XP): A rare autosomal‑recessive disorder that impairs DNA excision repair, making UV‑induced DNA damage accumulate.
• Lupus erythematosus (systemic or cutaneous): Autoimmune inflammation makes skin hypersensitive to UV light.
• Porphyrias: Metabolic disorders of heme synthesis (e.g., acute intermittent porphyria, erythropoietic protoporphyria) that cause photosensitivity.
• Drug‑induced photosensitivity: Antimalarials (chloroquine), tetracyclines, sulfonamides, fluoroquinolones, non‑steroidal anti‑inflammatory drugs (NSAIDs), and certain chemotherapeutic agents.
• Polymorphous light eruption (PMLE): An idiopathic, immune‑mediated reaction that usually appears in spring or early summer.
• Dermatomyositis: An inflammatory myopathy with characteristic Gottron papules and a heliotrope rash that worsens with sun exposure.
• Contact dermatitis to photosensitizing chemicals: Fragrances, certain preservatives, or plant-derived compounds (e.g., furocoumarins in citrus).
• Atopic dermatitis with photosensitivity: Some patients develop an exaggerated UV response as part of their eczema.
• Infectious diseases: Chronic hepatitis C and HIV can increase UV‑related skin reactions.
• Immune‑suppressive conditions: Organ transplant recipients on calcineurin inhibitors may exhibit heightened photosensitivity.

Associated Symptoms

Photosensitivity rarely occurs in isolation. Typical accompanying features include:

• Redness (erythema) that may appear minutes to hours after sun exposure.
• Burning or stinging sensation.
• Intense itching (pruritus) or a “cobblestone” feeling.
• Swelling (edema) especially around the eyes, lips, or hands.
• Blister formation or vesicles that rupture, leaving raw, painful areas.
• Dry, scaly patches that may become hyper‑pigmented (dark) or hypo‑pigmented (light) after healing.
• Systemic signs such as fever, malaise, joint pain, or oral ulcers when photosensitivity is part of a systemic disease (e.g., lupus).
• Appearance of characteristic rashes: “butterfly” malar rash in lupus, Gottron papules in dermatomyositis, or porcelain‑white lesions in porphyria.

When to See a Doctor

Most people can manage mild sunburn at home, but the following situations warrant prompt medical evaluation:

• Skin reaction develops after only a few minutes of normal sunlight.
• Blisters, severe pain, or swelling affect a large body surface area.
• Recurrent eruptions despite diligent sunscreen use.
• Presence of systemic symptoms (fever, joint pain, fatigue, mouth ulcers).
• New rash after starting a medication or supplement.
• History of skin cancer, family history of xeroderma pigmentosum, or other genetic disorders.
• Any ulcerated or non‑healing lesion persisting >2 weeks.

Early evaluation helps prevent complications, identify underlying systemic disease, and tailor protective strategies.

Diagnosis

Diagnosing photosensitivity involves a combination of history, physical examination, and targeted testing.

1. Detailed History

• Onset and pattern of skin changes (time of year, duration of sun exposure).
• Medication and supplement list (including over‑the‑counter).
• Family history of genetic photosensitivity disorders.
• Associated systemic complaints (joint pain, fatigue, abdominal pain).

2. Physical Examination

• Distribution of lesions (face, neck, extensor arms, hands).
• Morphology (erythema, vesicles, plaques, hyper‑pigmentation).
• Assessment for signs of underlying disease (malar rash, Gottron papules, oral ulcers).

3. Laboratory & Special Tests

• Autoimmune panels: ANA, anti‑dsDNA, anti‑Ro/La for lupus; anti‑Mi‑2, anti‑Jo‑1 for dermatomyositis.
• Porphyrin studies: Urine, plasma, and stool porphyrin levels; erythrocyte protoporphyrin.
• Genetic testing: Mutations in XPA–XPG genes for xeroderma pigmentosum.
• Phototesting: Controlled exposure to UVA/UVB in a clinic to reproduce the reaction.
• Skin biopsy: Histopathology can differentiate dermatitis, lupus, or porphyria.
• Complete blood count & liver function tests: To evaluate systemic involvement in porphyria or hepatitis‑related photosensitivity.

Treatment Options

Treatment is two‑pronged: **protect the skin from further UV exposure** and **address the underlying cause**.

1. Sun‑Protection Measures (First‑Line)

• Broad‑spectrum sunscreen (SPF 30‑50+) applied 15‑30 minutes before outdoor activity and reapplied every 2 hours.
• Physical (mineral) filters containing zinc oxide or titanium dioxide are less likely to cause irritation.
• Protective clothing: long‑sleeved shirts, wide‑brim hats, UV‑blocking sunglasses.
• Seek shade between 10 a.m. and 4 p.m. when UV index peaks.
• Window films that block UVA/UVB for indoor protection.

2. Pharmacologic Therapy

• Topical corticosteroids: Low‑ to mid‑potency creams (hydrocortisone 1%‑2.5% or triamcinolone) for acute inflammation.
• Systemic steroids: Short courses for severe flares (e.g., prednisone 0.5 mg/kg + taper).
• Antimalarials (hydroxychloroquine): Beneficial in lupus‑related photosensitivity; monitor retinal toxicity.
• Immunomodulators: Mycophenolate mofetil, azathioprine, or methotrexate for refractory autoimmune disease.
• Antihistamines: Non‑sedating agents (cetirizine, loratadine) to relieve itching.
• Beta‑carotene or nicotinamide: Oral agents shown to increase the minimal erythema dose in some photosensitivity disorders (e.g., PMLE).
• Porphyria‑specific therapy: High‑dose β‑carotene, afamelanotide (synthetic α‑MSH analogue), or hemin infusion for acute attacks.
• Vitamin D supplementation: Essential for patients who limit sun exposure, aiming for 800‑1,000 IU/day (adjust per labs).

3. Lifestyle & Home Care

• Cool compresses and oatmeal baths for symptomatic relief.
• Avoid tanning beds and artificial UV sources.
• Gentle skin moisturizers (ceramide‑rich) to repair the barrier after sun exposure.
• Maintain a sun‑exposure diary to identify triggers and optimal protection strategies.

Prevention Tips

Proactive steps can markedly reduce the frequency and severity of photosensitivity reactions:

• Daily sunscreen use: Even on cloudy days.
• Rotate medications: If a drug is suspected, discuss alternatives with your physician.
• Regular skin examinations: Self‑checks and annual dermatologist visits for early detection of precancerous changes.
• Dietary antioxidants: Foods rich in vitamins C, E, and polyphenols (berries, leafy greens) may support skin resilience.
• Protective eyewear: UV‑blocking sunglasses protect periorbital skin and eyes.
• Educate family members: Especially for hereditary conditions, members should be aware of avoidance strategies and the need for genetic counseling.
• Hydration and moisturization: Keep skin barrier intact to minimize cracking and dryness.

Emergency Warning Signs

Key Take‑aways

• Xeroderma (photosensitivity) is an abnormal skin reaction to UV light that can signal underlying genetic, autoimmune, drug‑related, or metabolic disorders.
• Identifying triggers, using rigorous sun protection, and treating the root cause are essential for long‑term control.
• Prompt medical evaluation is needed for severe, persistent, or systemic reactions.
• Regular follow‑up and skin surveillance help prevent complications such as actinic keratoses and skin cancer.

For personalized advice, always discuss symptoms and treatment options with a qualified dermatologist or primary‑care physician.

---

References: Mayo Clinic, CDC, National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, Journal of the American Academy of Dermatology, and peer‑reviewed dermatology texts (accessed 2024).

```